Literature DB >> 1293310

Strand scission in DNA by gossypol and Cu(II): role of Cu(I) and oxygen-free radicals.

R Zaidi1, S M Hadi.   

Abstract

Gossypol, a polyphenolic binaphthyl dialdehyde found in cotton seeds, is a dietary mutagen and a potential male contraceptive. In the presence of Cu(II), gossypol caused breakage of supercoiled plasmid pBR322 DNA. The products were relaxed circles or a mixture of these and linear molecules. Other metal ions tested [Ni(II), Co(II), Mn(II), and Fe(II)] were ineffective or less effective in the DNA breakage reaction. In the case of gossypol-Cu(II) mediated cleavage, Cu(I) was shown to be an essential intermediate by using the Cu(I) sequestering reagent bathocuproine. By using job plots, it was established that in the absence of DNA, eight Cu(II) ions can be reduced by one gossypol molecule. The involvement of active oxygen species, such as singlet oxygen and H2O2, was established by the inhibition of DNA breakage by catalase and by sodium azide. It was further shown that gossypol is capable of directly producing H2O2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1293310     DOI: 10.1002/jbt.2570070404

Source DB:  PubMed          Journal:  J Biochem Toxicol        ISSN: 0887-2082


  5 in total

Review 1.  Emerging Bcl-2 inhibitors for the treatment of cancer.

Authors:  Asfar S Azmi; Zhiwei Wang; Philip A Philip; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Expert Opin Emerg Drugs       Date:  2010-09-03       Impact factor: 4.191

Review 2.  Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy.

Authors:  Asfar S Azmi; Ramzi M Mohammad
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

3.  Induction of neutrophil Mac-1 integrin expression and superoxide production by the medicinal plant extract gossypol.

Authors:  P Benhaim; S J Mathes; T K Hunt; H Scheuenstuhl; C C Benz
Journal:  Inflammation       Date:  1994-10       Impact factor: 4.092

4.  Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy.

Authors:  Ashiq Masood; Asfar S Azmi; Ramzi M Mohammad
Journal:  Cancers (Basel)       Date:  2011-06-01       Impact factor: 6.639

Review 5.  High drug-loading nanomedicines: progress, current status, and prospects.

Authors:  Shihong Shen; Youshen Wu; Yongchun Liu; Daocheng Wu
Journal:  Int J Nanomedicine       Date:  2017-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.